Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Guy

Showing results (541-550 of 587) with videos related to

Pageof 59
Sort By:
Bioorganic & Medicinal Chemistry Letters|October 16, 2010
Discovery and synthesis of 6,7,8,9-tetrahydro-5H-pyrimido-[4,5-d]azepines as novel TRPV1 antagonistsNatalie A Hawryluk, Jeffrey E Merit, Alec D Lebsack, et al.
Journal of Molecular Biology|May 14, 2003
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitorsBradley A Katz, Kyle Elrod, Erik Verner, et al.
BMC Infectious Diseases|October 22, 2013
A randomised trial of point-of-care tests for chlamydia and gonorrhoea infections in remote Aboriginal communities: Test, Treat ANd GO- the "TTANGO" trial protocolRebecca J Guy, Lisa Natoli, James Ward, et al.
Bioorganic & Medicinal Chemistry Letters|November 29, 2008
Identification and synthesis of 2,7-diamino-thiazolo[5,4-d]pyrimidine derivatives as TRPV1 antagonistsAlec D Lebsack, Bryan J Branstetter, Michael D Hack, et al.
The Lancet. Infectious Diseases|October 11, 2018
Molecular point-of-care testing for chlamydia and gonorrhoea in Indigenous Australians attending remote primary health services (TTANGO): a cluster-randomised, controlled, crossover trialRebecca J Guy, James Ward, Louise M Causer, et al.
ACS Medicinal Chemistry Letters|December 30, 2015
Preclinical Characterization of the FAAH Inhibitor JNJ-42165279John M Keith, William M Jones, Mark Tichenor, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Aryl Piperazinyl Ureas as Inhibitors of Fatty Acid Amide Hydrolase (FAAH) in Rat, Dog, and PrimateJohn M Keith, Rich Apodaca, Mark Tichenor, et al.
Plos Computational Biology|November 4, 2021
Modelling response strategies for controlling gonorrhoea outbreaks in men who have sex with men in AustraliaQibin Duan, Chris Carmody, Basil Donovan, et al.
BMC Infectious Diseases|December 15, 2015
Rationale and design of FORTH: a randomised controlled trial assessing the effectiveness of HIV self-testing in increasing HIV testing frequency among gay and bisexual menMuhammad S Jamil, Garrett Prestage, Christopher K Fairley, et al.
Bioorganic & Medicinal Chemistry Letters|February 12, 2014
1-Aryl-2-((6-aryl)pyrimidin-4-yl)amino)ethanols as competitive inhibitors of fatty acid amide hydrolaseJohn M Keith, Natalie Hawryluk, Richard L Apodaca, et al.
Pageof 59

Showing results (541-550 of 587) with videos related to

Sort By:
Pageof 59
Bioorganic & Medicinal Chemistry Letters|October 16, 2010
Discovery and synthesis of 6,7,8,9-tetrahydro-5H-pyrimido-[4,5-d]azepines as novel TRPV1 antagonistsNatalie A Hawryluk, Jeffrey E Merit, Alec D Lebsack, et al.
Journal of Molecular Biology|May 14, 2003
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitorsBradley A Katz, Kyle Elrod, Erik Verner, et al.
BMC Infectious Diseases|October 22, 2013
A randomised trial of point-of-care tests for chlamydia and gonorrhoea infections in remote Aboriginal communities: Test, Treat ANd GO- the "TTANGO" trial protocolRebecca J Guy, Lisa Natoli, James Ward, et al.
Bioorganic & Medicinal Chemistry Letters|November 29, 2008
Identification and synthesis of 2,7-diamino-thiazolo[5,4-d]pyrimidine derivatives as TRPV1 antagonistsAlec D Lebsack, Bryan J Branstetter, Michael D Hack, et al.
The Lancet. Infectious Diseases|October 11, 2018
Molecular point-of-care testing for chlamydia and gonorrhoea in Indigenous Australians attending remote primary health services (TTANGO): a cluster-randomised, controlled, crossover trialRebecca J Guy, James Ward, Louise M Causer, et al.
ACS Medicinal Chemistry Letters|December 30, 2015
Preclinical Characterization of the FAAH Inhibitor JNJ-42165279John M Keith, William M Jones, Mark Tichenor, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Aryl Piperazinyl Ureas as Inhibitors of Fatty Acid Amide Hydrolase (FAAH) in Rat, Dog, and PrimateJohn M Keith, Rich Apodaca, Mark Tichenor, et al.
Plos Computational Biology|November 4, 2021
Modelling response strategies for controlling gonorrhoea outbreaks in men who have sex with men in AustraliaQibin Duan, Chris Carmody, Basil Donovan, et al.
BMC Infectious Diseases|December 15, 2015
Rationale and design of FORTH: a randomised controlled trial assessing the effectiveness of HIV self-testing in increasing HIV testing frequency among gay and bisexual menMuhammad S Jamil, Garrett Prestage, Christopher K Fairley, et al.
Bioorganic & Medicinal Chemistry Letters|February 12, 2014
1-Aryl-2-((6-aryl)pyrimidin-4-yl)amino)ethanols as competitive inhibitors of fatty acid amide hydrolaseJohn M Keith, Natalie Hawryluk, Richard L Apodaca, et al.
Pageof 59